QVINTIP®: BASATO SU SISTEMI DI RICERCA SVEDESE

Qvintip® ha solide basi cliniche ed è stato valutato in collaborazione con il Laboratorio Citologico dell’Ospedale Accademico Universitario di Uppsala, in Svezia. La collaborazione con i ricercatori rimane una delle nostre basi. Ad oggi, Qvintip è stato studiato in 25 studi clinici su un campione di 90,000 donne e ulteriori prove cliniche sono in corso su altre 15,000 donne. 

A seguire la lista degli studi scientifici selezionati

• Banner et al, British Journal of Cancer, 2009; 101; 871-874 “Self-sampling of the vaginal fluid at home combined with high-risk HPV testing”

• Wikström et al, Acta Obs et Gyn. 2007; 86 “Attitudes to self-sampling of vaginal smear for HPV analysis among women not attending organized cytological screening”

• Stenvall et al, Acta Derm Veneorol 2007; 87 “High prevalence of oncogenic HPV in women not attending organized cytological screening”

• Wikström et al, Acta Derm Veneorol 2007; 87 “Low prevalence of HR-HPV in older women not attending organized cytological screening: a pilot study”

• Stenvall H et al, Acta Obstetricia et Gynecologica. 2007; 86 “Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device”

• I Wikström et al. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. British Journal of Cancer 105, 337-339 (26 July 2011) | doi:10.1038/bjc.2011.236

• Gyllensten U et al. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer. Br J Cancer 2011 Aug 23;105(5):694-7. doi: 10.1038/bjc.2011.277. Epub 2011 Aug 2

• Ronco et al Efficacy of Human Papilloma Virus testing for the detection of invasive cervical cancers and cervical intraepithial neoplasia; a randomized controlled trial. Lancet oncology 2010;11;249-57